Uría Menéndez and Latham & Watkins advise on Euromed deal
Uría Menéndez and Latham & Watkins were instructed in connection with the €82m sale of herbal extract manufacturer Euromed to The Riverside Company.
Uría Menéndez advised The Riverside Company, while Latham & Watkins advised the seller, Swedish company Meda AB, according to Mergermarket.
The total consideration is €82m in upfront cash for the shares of Euromed, which generates sales of around €40m and an EBITDA margin of around 20 per cent on an annual basis.
One of Euromed’s primary products is the “liver health” supplement Legalon API.
